TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22565898

Group type: EXPERIMENTAL
Intervention: Iliac crest flap
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fibular flap
Number of subjects: 0
Study: 20980657

Group type: EXPERIMENTAL
Intervention: Fortified complementary food (FC)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Fortified flour (FF)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 246
Study: 18773822

Group type: EXPERIMENTAL
Intervention: New One‐Stitch technique
Number of subjects: 445

Group type: COMPARATOR
Intervention: Lich‐Gregoir technique
Number of subjects: 445
Study: 15836685

Group type: EXPERIMENTAL
Intervention: Hypercapnia (end‐tidal CO(2) = 45 mmHg) with thiopental and isoflurane (TI)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normocapnia (end‐tidal CO(2) = 35 mmHg) with thiopental and isoflurane (TI)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hypercapnia (end‐tidal CO(2) = 45 mmHg) with propofol (P)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normocapnia (end‐tidal CO(2) = 35 mmHg) with propofol (P)
Number of subjects: 24
Study: 11703572

Group type: EXPERIMENTAL
Intervention: Interferon (IFN) plus ribavirin for 48 weeks
Number of subjects: 912

Group type: EXPERIMENTAL
Intervention: Interferon (IFN) plus ribavirin for 24 weeks
Number of subjects: 912

Group type: COMPARATOR
Intervention: Interferon (IFN) alone for 24 weeks
Number of subjects: 912
Study: 9143608

Group type: EXPERIMENTAL
Intervention: D0870 (50 mg initial dose followed by 10 mg for 4 days)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: D0870 (100 mg initial dose followed by 25 mg for 4 days)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: D0870 (100 mg initial dose followed by 10 mg for 5 days)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 35
Study: 8196572

Group type: EXPERIMENTAL
Intervention: Mexiletine (450 mg per day)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Mexiletine
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 3310504

Group type: EXPERIMENTAL
Intervention: 5% dextrose solution (dextrose group)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Hartmann's solution (Hartmann group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No intravenous infusion (control group)
Number of subjects: 48
Study: 29382398

Group type: EXPERIMENTAL
Intervention: Unmanned Aerial Vehicle (UAV) technology
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard Practice (SP)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: UAV
Number of subjects: 21

Group type: COMPARATOR
Intervention: SP
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 21
Study: 26810770

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Insecure-dismissing attachment style
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Patient characteristics (Black American, younger, never married, poorer)
Number of subjects: 237
Study: 23490463

Group type: EXPERIMENTAL
Intervention: Robotic Gait Training
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Treadmill Training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Physical Therapy
Number of subjects: 60
Study: 21177084

Group type: EXPERIMENTAL
Intervention: bakumondoto
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no bakumondoto)
Number of subjects: 24
Study: 19564317

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 355

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Indomethacin and Placebo
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Severe brain injury
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Socioeconomic factors
Number of subjects: 355
Study: 16389065

Group type: EXPERIMENTAL
Intervention: Individualized (broad) cognitive behavioral therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Manual‐based (focused) cognitive behavioral therapy
Number of subjects: 50
Study: 15172366

Group type: EXPERIMENTAL
Intervention: Volumetric implementations of model observers (channelized hotelling observer and non-prewhitening matched filter)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Human observer detection performance
Number of subjects: 0
Study: 11251036

Group type: EXPERIMENTAL
Intervention: Hydrocortisone infusion (100 mg followed by continuous infusion of 0.18 mg/kg per h)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study: 9235736

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) 2.0 IU/m2, Norditropin
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 7516831

Group type: EXPERIMENTAL
Intervention: Serum PSA and DRE as first approach, followed by TRUS if abnormal
Number of subjects: 7350

Group type: EXPERIMENTAL
Intervention: DRE in addition to PSA
Number of subjects: 7350

Group type: EXPERIMENTAL
Intervention: Serum PSA alone for follow-ups every second year
Number of subjects: 7350

Group type: EXPERIMENTAL
Intervention: Current detection strategy
Number of subjects: 7350
Study: 3222164

Group type: EXPERIMENTAL
Intervention: Imipenem-cilastatin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Clindamycin plus gentamicin
Number of subjects: 20
Study: 30051954

Group type: EXPERIMENTAL
Intervention: Deproteinized bovine bone mineral (DBBM)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Deproteinized porcine bone mineral (DPBM)
Number of subjects: 100
Study: 28851406

Group type: EXPERIMENTAL
Intervention: Inlife social support intervention
Number of subjects: 122

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 122
Study: 25287137

Group type: EXPERIMENTAL
Intervention: Mindfulness stress management program (8 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 38
Study: 24473957

Group type: EXPERIMENTAL
Intervention: Manual chest vibrocompression, nasotracheal suctioning, and resting
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group with 30 minutes of rest
Number of subjects: 20
Study: 21168838

Group type: EXPERIMENTAL
Intervention: Balanced propofol sedation (BPS)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Conventional sedation
Number of subjects: 222
Study: 18648123

Group type: EXPERIMENTAL
Intervention: Behavioral intervention rewarding increases in physical activity with TV time (400 counts of PA earns 1 hour of TV)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (wore activity monitors with free access to TV)
Number of subjects: 30
Study: 22230409

Group type: EXPERIMENTAL
Intervention: Lactobacillus salivarius LS01 (probiotic treatment)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 38
Study: 16024583

Group type: EXPERIMENTAL
Intervention: Sevoflurane at end-tidal concentrations of 2.0% and 3.0%
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Sevoflurane at end-tidal concentration of 4.0%
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Correlation of BIS with age
Number of subjects: 81
Study: 11888362

Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 0

Group type: COMPARATOR
Intervention: Megestrol
Number of subjects: 0
Study: 9405729

Group type: EXPERIMENTAL
Intervention: Vitamin D3 group (vitamin D3 300 IU/day + calcium lactate 500 mg/day)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: HRT + Vit D3 group (2 mg estradiol valerate + 1 mg cyproterone acetate + vitamin D3 300 IU/day + calcium lactate 500 mg/day)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: HRT group (2 mg estradiol valerate + 1 mg cyproterone acetate)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo group (calcium lactate 500 mg/day)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Non-hormone groups (Vit D3 and placebo)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Hormone groups (HRT and HRT + Vit D3)
Number of subjects: 72
Study: 7861792

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 2471407

Group type: EXPERIMENTAL
Intervention: Office health education program (slide-tape presentation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 29405761

Group type: EXPERIMENTAL
Intervention: Healing Light Guided Imagery (HLGI)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Wait-list control (journaling)
Number of subjects: 17
Study: 28751158

Group type: EXPERIMENTAL
Intervention: MOMS program (Mentors Offering Maternal Support)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Normal prenatal care
Number of subjects: 246
Study: 26654905

Group type: EXPERIMENTAL
Intervention: Iodine supplementation (150 μg/d)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 24054920

Group type: EXPERIMENTAL
Intervention: LAA occlusion
Number of subjects: 51

Group type: COMPARATOR
Intervention: No occlusion and oral anticoagulation
Number of subjects: 51
Study: 21914595

Group type: EXPERIMENTAL
Intervention: X‐Glove (custom orthotic glove)
Number of subjects: 5

Group type: COMPARATOR
Intervention: No glove (control condition)
Number of subjects: 5
Study: 18992651

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Balloon angioplasty (BA)
Number of subjects: 150
Study: 16526878

Group type: EXPERIMENTAL
Intervention: Post-LASIK eyes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal healthy eyes
Number of subjects: 0
Study: 14522569

Group type: EXPERIMENTAL
Intervention: Clopidogrel (loading dose 300 mg, followed by 75 mg daily) with pre-treatment of atorvastatin or simvastatin
Number of subjects: 47

Group type: COMPARATOR
Intervention: Clopidogrel (loading dose 300 mg, followed by 75 mg daily)
Number of subjects: 47
Study: 10998024

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate nasal drops 400 microgram once daily
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 8641498

Group type: EXPERIMENTAL
Intervention: Leukocyte rates in semen using an immunocytochemical method for differentiation of round cells
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Measurement of polymorphonuclear (PMN) granulocyte elastase concentration in seminal plasma
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Semen cultures as screening for subclinical infection of the male genital tract
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Determination of local antisperm antibodies (Ab) with the mixed antiglobulin reaction (MAR) immunoglobulin (Ig) G and IgA
Number of subjects: 191
Study: 1474533

Group type: EXPERIMENTAL
Intervention: Nabumetone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6085376

Group type: EXPERIMENTAL
Intervention: Nitrendipine (NTP) 5 mg b.i.d. (increased to 20 mg b.i.d. as needed) + Hydrochlorothiazide (HCTZ) 25 mg daily
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (PLA) b.i.d. + Hydrochlorothiazide (HCTZ) 25 mg daily
Number of subjects: 86
Study: 29579168

Group type: EXPERIMENTAL
Intervention: Apixaban (5 mg b.i.d.)
Number of subjects: 674

Group type: COMPARATOR
Intervention: Vitamin K antagonists (VKA, INR 2-3)
Number of subjects: 674

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 674

Group type: COMPARATOR
Intervention: VKA
Number of subjects: 674

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 674
Study: 25666587

Group type: EXPERIMENTAL
Intervention: TheraBite jaw rehabilitation device (TB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Speech Language Pathology (SLP) sessions
Number of subjects: 0
Study: 25725191

Group type: EXPERIMENTAL
Intervention: Project EX (intervention group)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 211
Study: 22964078

Group type: EXPERIMENTAL
Intervention: Bereavement management program
Number of subjects: 402

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 402
Study: 20811347

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors (ACEIs)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blockers (ARBs)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: ACEIs and ARBs combined
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: ACEIs and ARBs
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: ACEIs and ARBs in patients receiving amiodarone
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: ACEIs and ARBs in patients with heart failure
Number of subjects: 26
Study: 18387384

Group type: EXPERIMENTAL
Intervention: Rapid PSA results (within 15 minutes)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Delayed PSA results (1 to 4 days by telephone)
Number of subjects: 188
Study: 16623818

Group type: EXPERIMENTAL
Intervention: Caspofungin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Liposomal amphotericin B
Number of subjects: 0
Study: 15219340

Group type: EXPERIMENTAL
Intervention: Smoking abstinence for 2 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Continued smoking for 2 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Smoking abstinence and continued smoking
Number of subjects: 60
Study: 11695288

Group type: EXPERIMENTAL
Intervention: 1.5% lignocaine with 1/200,000 adrenaline
Number of subjects: 155

Group type: COMPARATOR
Intervention: 1.5% mepivacaine
Number of subjects: 155
Study: 9203648

Group type: EXPERIMENTAL
Intervention: Hyperimmune anti-HIV intravenous immunoglobulin (HIVIG) 200 mg/kg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Hyperimmune anti-HIV intravenous immunoglobulin (HIVIG)
Number of subjects: 28
Study: 7862820

Group type: EXPERIMENTAL
Intervention: 15 mg oxazepam
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 30 mg oxazepam
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 3680599

Group type: EXPERIMENTAL
Intervention: 75 mg sustained release (SR) preparation
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 25 mg tid dosing regimen
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: SR PPA 75 mg
Number of subjects: 150
Study: 30290638

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 235

Group type: COMPARATOR
Intervention: Nonanticoagulant
Number of subjects: 235
Study: 27542302

Group type: EXPERIMENTAL
Intervention: Adalimumab (loading dose 80 mg; biweekly dose 40 mg)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 229
Study: 26386802

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg intravenous enoxaparin
Number of subjects: 910

Group type: COMPARATOR
Intervention: unfractionated heparin
Number of subjects: 910
Study: 23885702

Group type: EXPERIMENTAL
Intervention: 1.5 g/day high‐oleic sunflower ethyl ester oil softgel capsules + foods containing 7 g/day stearidonic acid soybean oil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1.5 g/day EPA oil ethyl ester softgel capsules + foods containing 7 g/day high‐oleic sunflower oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1.5 g/day high‐oleic sunflower ethyl ester oil softgel capsules + foods containing 7 g/day high‐oleic sunflower oil
Number of subjects: 0
Study: 20578930

Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg MPH
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg MPH
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 18196427

Group type: EXPERIMENTAL
Intervention: Standard class plus a joint-specific module addressing recovery during the first 12 months for THA patients.
Number of subjects: 320

Group type: COMPARATOR
Intervention: Standard THA or TKA class addressing recovery immediately after surgery for control patients.
Number of subjects: 320
Study: 16263834

Group type: EXPERIMENTAL
Intervention: r-hGH (0.2 U/kg.d)
Number of subjects: 12
Study: 14725382

Group type: EXPERIMENTAL
Intervention: Toothpaste containing 2% zinc citrate and 0.3% Triclosan
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Toothpaste containing 2% zinc citrate and 0.3% Triclosan after morning brushing and controlled food intake
Number of subjects: 104
Study: 10203935

Group type: EXPERIMENTAL
Intervention: Nicotine cigarette (.7‐mg estimated nicotine delivery)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo cigarette (.05‐mg nicotine delivery)
Number of subjects: 10
Study: 7726803

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment
Number of subjects: 105
Study: 1981363

Group type: EXPERIMENTAL
Intervention: Enteric-coated mesalamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sulphasalazine
Number of subjects: 0
Study: 7361347

Group type: EXPERIMENTAL
Intervention: Flavoxate
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Emepronium
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Propantheline
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 29453872

Group type: EXPERIMENTAL
Intervention: Dermatology consultation within 24 hours of hospitalization
Number of subjects: 175

Group type: COMPARATOR
Intervention: Standard of care (treatment by primary medicine team)
Number of subjects: 175
Study: 26917504

Group type: EXPERIMENTAL
Intervention: RCT-18 (180 mg, once or twice weekly)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: RCT-18 (360 mg, weekly)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 25033590

Group type: EXPERIMENTAL
Intervention: Educational program on sun protection
Number of subjects: 3205
Study: 23190707

Group type: EXPERIMENTAL
Intervention: Hydrofiber dressings with low silver content
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hydrofiber dressings with high silver content
Number of subjects: 30

Group type: COMPARATOR
Intervention: Antiseptics-free dressings
Number of subjects: 30
Study: 20657778

Group type: EXPERIMENTAL
Intervention: Mixed methods and triangulation model for data collection
Number of subjects: 725

Group type: EXPERIMENTAL
Intervention: Qualitative social science integration
Number of subjects: 725
Study: 18410811

Group type: EXPERIMENTAL
Intervention: Hair apposition technique performed by doctors
Number of subjects: 164

Group type: COMPARATOR
Intervention: Hair apposition technique performed by nurses
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Overall outcomes (wound infection, wound healing, bleeding, overall complications)
Number of subjects: 164
Study: 16633117

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment group (ATG) with ofloxacin or levofloxacin (single dose or BID for 5 days)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Supportive treatment only group (STG)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment group (ATG)
Number of subjects: 139
Study: 12660335

Group type: EXPERIMENTAL
Intervention: Diltiazem 120 mg/d
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Diltiazem 180 mg/d
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Diltiazem 240 mg/d
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Sustained-release diltiazem 120 mg twice daily
Number of subjects: 196
Study: 10550737

Group type: EXPERIMENTAL
Intervention: Mometasone furoate 100 microg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Mometasone furoate 200 microg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Budesonide 400 microg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 9051708

Group type: EXPERIMENTAL
Intervention: 20 mg domperidone
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 2013952

Group type: EXPERIMENTAL
Intervention: Opinion leader education
Number of subjects: 76

Group type: COMPARATOR
Intervention: Audit and feedback
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 76
Study: 7071529

Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine (subcutaneous injection)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Influenza vaccine (subcutaneous injection)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine (intramuscular injection)
Number of subjects: 281
Study: 3908116

Group type: EXPERIMENTAL
Intervention: 500 mg AG/day
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: 1 g AG/day
Number of subjects: 170

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 170
Study: 29596644

Group type: EXPERIMENTAL
Intervention: Compound-level intervention (chlorinated drinking water, upgraded sanitation, and handwashing promotion)
Number of subjects: 1799

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 1799
Study: 24963025

Group type: EXPERIMENTAL
Intervention: Low-dose S-IFE (1 g/kg/d)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control dose S-IFE (approximately 3 g/kg/d)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Low-dose S-IFE
Number of subjects: 136

Group type: COMPARATOR
Intervention: Low-dose S-IFE and Control dose S-IFE
Number of subjects: 136
Study: 25631721

Group type: EXPERIMENTAL
Intervention: Probiotic milk (Lactobacillus casei Shirota) for 10 days
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control milk for 10 days
Number of subjects: 31
Study: 22551822

Group type: EXPERIMENTAL
Intervention: EPCs and EMPs in patients with arterial ED and MetS
Number of subjects: 50

Group type: COMPARATOR
Intervention: EPCs and EMPs in patients with MetS but without ED
Number of subjects: 50

Group type: COMPARATOR
Intervention: EPCs and EMPs in patients without MetS and ED
Number of subjects: 50
Study: 19653027

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 5804

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5804
Study: 18548958

Group type: EXPERIMENTAL
Intervention: Pure cotton cord
Number of subjects: 340

Group type: COMPARATOR
Intervention: Cord impregnated with epinephrine
Number of subjects: 340

Group type: COMPARATOR
Intervention: Chemical retraction (Expa-syl)
Number of subjects: 340
Study: 16052544

Group type: EXPERIMENTAL
Intervention: Fast-releasing ER formulation
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Medium-releasing ER formulation
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Slow-releasing ER formulation
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Slightly-fast-releasing ER formulation
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Slightly-slow-releasing ER formulation
Number of subjects: 52

Group type: COMPARATOR
Intervention: 12-h IV infusion of valproic acid (reference)
Number of subjects: 52